Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 105.21
-2.28 (-2.12%)
Aug 1, 2025, 3:30 PM IST
Brightcove Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 3,803 | 4,055 | 3,818 | 3,543 | 3,946 | 2,307 | Upgrade | |
Revenue Growth (YoY) | -6.81% | 6.22% | 7.74% | -10.21% | 71.07% | 14.43% | Upgrade |
Cost of Revenue | 1,431 | 1,320 | 1,389 | 1,209 | 1,509 | 801.35 | Upgrade |
Gross Profit | 2,372 | 2,735 | 2,429 | 2,334 | 2,437 | 1,505 | Upgrade |
Selling, General & Admin | 996.3 | 963.76 | 997.86 | 781.03 | 610.08 | 443.62 | Upgrade |
Other Operating Expenses | 1,276 | 1,281 | 915.99 | 878.76 | 870.91 | 566.8 | Upgrade |
Operating Expenses | 2,373 | 2,344 | 2,036 | 1,765 | 1,576 | 1,096 | Upgrade |
Operating Income | -0.67 | 391.2 | 392.59 | 569.56 | 861.55 | 409.46 | Upgrade |
Interest Expense | -101.51 | -100.4 | -76.28 | -79.9 | -65.37 | -109.66 | Upgrade |
Interest & Investment Income | - | - | 24.45 | 47.52 | 37.19 | 23.4 | Upgrade |
Earnings From Equity Investments | -1.87 | 59.25 | 188.05 | 136.18 | 113.4 | 94.75 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 16.72 | 32.27 | 15.24 | 5.81 | Upgrade |
Other Non Operating Income (Expenses) | 46.7 | 46.7 | -11.11 | 19.51 | -9.39 | -10.46 | Upgrade |
Pretax Income | -57.35 | 396.75 | 534.43 | 725.15 | 952.62 | 413.31 | Upgrade |
Income Tax Expense | 33.36 | 98.42 | 99.2 | 156.14 | 223.81 | 56.28 | Upgrade |
Earnings From Continuing Operations | -90.72 | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Net Income | -90.71 | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade |
Net Income to Common | -90.71 | 298.33 | 435.24 | 569.01 | 728.81 | 357.03 | Upgrade |
Net Income Growth | - | -31.46% | -23.51% | -21.93% | 104.13% | 44.07% | Upgrade |
Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade |
Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade |
Shares Change (YoY) | -0.01% | -0.14% | 0.03% | 0.01% | 0.28% | 0.04% | Upgrade |
EPS (Basic) | -0.98 | 3.24 | 4.73 | 6.18 | 7.92 | 3.89 | Upgrade |
EPS (Diluted) | -0.98 | 3.24 | 4.72 | 6.17 | 7.91 | 3.88 | Upgrade |
EPS Growth | - | -31.36% | -23.50% | -21.97% | 103.58% | 44.01% | Upgrade |
Free Cash Flow | - | 192.84 | 36.76 | -126.55 | 137.67 | 389.36 | Upgrade |
Free Cash Flow Per Share | - | 2.09 | 0.40 | -1.37 | 1.49 | 4.24 | Upgrade |
Dividend Per Share | - | 0.500 | 0.500 | 0.500 | 0.500 | 0.430 | Upgrade |
Dividend Growth | - | - | - | - | 16.28% | 145.71% | Upgrade |
Gross Margin | 62.37% | 67.45% | 63.62% | 65.88% | 61.77% | 65.26% | Upgrade |
Operating Margin | -0.02% | 9.65% | 10.28% | 16.07% | 21.83% | 17.75% | Upgrade |
Profit Margin | -2.38% | 7.36% | 11.40% | 16.06% | 18.47% | 15.48% | Upgrade |
Free Cash Flow Margin | - | 4.75% | 0.96% | -3.57% | 3.49% | 16.88% | Upgrade |
EBITDA | 93.96 | 490.48 | 510.5 | 666.88 | 947.1 | 488.82 | Upgrade |
EBITDA Margin | 2.47% | 12.10% | 13.37% | 18.82% | 24.00% | 21.19% | Upgrade |
D&A For EBITDA | 94.63 | 99.29 | 117.91 | 97.32 | 85.55 | 79.35 | Upgrade |
EBIT | -0.67 | 391.2 | 392.59 | 569.56 | 861.55 | 409.46 | Upgrade |
EBIT Margin | -0.02% | 9.65% | 10.28% | 16.07% | 21.83% | 17.75% | Upgrade |
Effective Tax Rate | - | 24.81% | 18.56% | 21.53% | 23.49% | 13.62% | Upgrade |
Revenue as Reported | 3,850 | 4,102 | 3,865 | 3,658 | 4,012 | 2,343 | Upgrade |
Advertising Expenses | - | - | 152.07 | 101.5 | 80.56 | 35.38 | Upgrade |
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.